Yes.
That will be a huge development.
The company will not only start developing a revenue stream from those sales, but it will receive potentially valuable data.
I do not know this for a fact, but I imagine that data might prove useful in the package submitted to the FDA for IHL42x's NDA.
There are some folks in this forum who have OSA: would any of you seek through your doctor to have access to IHL42x under the SAS? If so, it would be amazing to get your feedback when that time comes.
- Forums
- ASX - By Stock
- IHL
- Ann: IHL-42X patent update & open label extension study approval
Ann: IHL-42X patent update & open label extension study approval, page-104
-
- There are more pages in this discussion • 97 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)